Abstract
Background:
Stroke is a leading cause of death and disability worldwide; however, no effective treatment currently exists.
Methods and results:
Rats receiving subcutaneous granulocyte colony-stimulating factor (G-CSF) showed less cerebral infarction, as evaluated by MRI, and improved motor performance after right middle cerebral artery ligation than vehicle-treated control rats. Subcutaneous administration of G-CSF enhanced the availability of circulating hematopoietic stem cells to the brain and their capacity for neurogenesis and angiogenesis in rats with cerebral ischemia.
Conclusions:
G-CSF induced increases in bone marrow cell mobilization and targeting to the brain, reducing the volume of cerebral infarction and improving neural plasticity and vascularization.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biomarkers
-
Bone Marrow / drug effects
-
Brain Chemistry
-
Cell Differentiation
-
Cell Division
-
Cell Lineage
-
DNA Replication
-
Drug Evaluation, Preclinical
-
Granulocyte Colony-Stimulating Factor / administration & dosage
-
Granulocyte Colony-Stimulating Factor / therapeutic use*
-
Head Movements
-
Hematopoietic Stem Cell Mobilization*
-
Hematopoietic Stem Cells / cytology
-
Hematopoietic Stem Cells / drug effects*
-
Infarction, Middle Cerebral Artery / physiopathology
-
Infarction, Middle Cerebral Artery / therapy*
-
Injections, Subcutaneous
-
Locomotion
-
Male
-
Neovascularization, Physiologic / drug effects
-
Neuronal Plasticity / drug effects
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, CXCR4 / biosynthesis
-
Receptors, CXCR4 / genetics
-
Recovery of Function
-
Up-Regulation
Substances
-
Biomarkers
-
Cxcr4 protein, rat
-
Receptors, CXCR4
-
Granulocyte Colony-Stimulating Factor